Syntekabio Inc.

Welcome to Syntekabio Inc. – Your Leading AI Drug Discovery and Development Partner Syntekabio is a pioneering biotech firm headquartered in South Korea, with a vibrant presence in the United States. Our core mission is to redefine the landscape of drug discovery and development by harnessing the transformative potential of Artificial Intelligence (AI) and Next Generation Sequencing (NGS). At Syntekabio, we merge cutting-edge technologies, boasting a robust genomic database and AI-driven algorithms, with our proprietary supercomputing infrastructure. This synergistic approach empowers us to forecast and pinpoint promising new molecular entities, laying the groundwork for groundbreaking advancements in drug development. Driven by our commitment to innovation and patient-centric care, Syntekabio is dedicated to delivering novel therapies that extend and enhance lives. We actively seek collaborations with esteemed academic institutions, industrial partners, and government research labs to drive transformative advancements in medicine on a global scale. Conveniently located in New York City, Syntekabio USA serves as our hub for innovation and collaboration. Visit our website at www.syntekabio.com to explore our cutting-edge AI and NGS-based technologies and join us on our journey to shape the future of healthcare. "Syntekabio is at the forefront of pioneering AI-driven drug discovery and development initiatives across diverse domains."